ESC Professional Premium Access

How to prevent best prevent stroke in atrial fibrillation patients

Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Date: 28 August 2022
Time: 12:15 - 12:45

Congress Session

6 presentations in this session

Thromboembolic risk dynamics, integrated care management and outcomes in patients with atrial fibrillation: a proof-of-concept analysis from the SPORTIF trials

Speaker: Doctor M. Proietti (Milan, IT)

Longitudinal changes in CHA2DS2-VASc and HAS-BLED scores are superior to baseline score values for predicting ischemic stroke and major bleeding in atrial fibrillation patients

Speaker: Doctor J. Rivera-Caravaca (Murcia, ES)

External validation of the biomarker based ABCD score in atrial fibrillation patients with a non gender CHA2DS2 VASc score 0 to 1, A Korean multicenter retrospective cohort

Speaker: Assistant Professor M. Jung (Seoul, KR)

The impact of mitral regurgitation on the incidence of stroke in patients with atrial fibrillation

Speaker: Assistant Professor M. Hieda (Fukuoka, JP)

Usefulness of echocardiographic parameters in predicting the incidence of ischemic stroke in japanese patients with non-valvular atrial fibrillation.

Speaker: Doctor Y. Tezuka (Kyoto, JP)
Speaker: Doctor M. Akao (Kyoto, JP)

Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: impact of atrial fibrillation

Speaker: Mr M. Alobaida (Liverpool, GB)

7 speakers from this session

Doctor Marco Proietti

IRCCS Clinical Scientific Institute Maugeri, Milan (Italy)
6 presentations
0 follower

Doctor Jose Miguel Rivera-Caravaca

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
2 presentations
0 follower

Assistant Professor Moonki Jung

Chung-Ang University, Seoul (Korea (Republic of))
0 follower

Assistant Professor Michinari Hieda

Kyushu University Hospital, Fukuoka (Japan)
0 follower

Doctor Yuji Tezuka

Mitsubishi Kyoto Hospital, Kyoto (Japan)
0 follower

Doctor Masaharu Akao

Kyoto Medical Centre, Kyoto (Japan)
5 presentations
0 follower

Mr Muath Alobaida

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk